We are pleased to announce our clinical research study designed to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis. Iontophoresis is an investigational drug delivery system which was developed as a means to non-invasively deliver dexamethasone into the eye.

Uveitis is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the outer fibrous layer composed of the sclera and cornea.